PerkinElmer, Inc. (NYSE:PKI) declared a quarterly dividend on Friday, October 27th, RTT News reports. Shareholders of record on Friday, January 19th will be given a dividend of 0.07 per share by the medical research company on Friday, February 9th. This represents a $0.28 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, January 18th.

PerkinElmer has a dividend payout ratio of 9.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect PerkinElmer to earn $3.29 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 8.5%.

PerkinElmer (PKI) opened at $78.89 on Friday. PerkinElmer has a 1-year low of $50.59 and a 1-year high of $79.02. The company has a current ratio of 2.59, a quick ratio of 2.09 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $8,555.68, a price-to-earnings ratio of 27.92, a price-to-earnings-growth ratio of 1.87 and a beta of 0.77.

In related news, insider Frank Anders Wilson sold 37,535 shares of the company’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $70.14, for a total value of $2,632,704.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Andrew Okun sold 12,680 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $72.00, for a total transaction of $912,960.00. Following the completion of the sale, the insider now owns 25,121 shares of the company’s stock, valued at approximately $1,808,712. The disclosure for this sale can be found here. In the last three months, insiders sold 86,336 shares of company stock worth $6,114,917. 2.20% of the stock is currently owned by company insiders.

Several research firms have issued reports on PKI. Citigroup reaffirmed a “buy” rating and set a $80.00 price objective (up previously from $74.00) on shares of PerkinElmer in a report on Tuesday, September 26th. Zacks Investment Research raised PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a report on Monday, January 8th. Goldman Sachs Group reaffirmed a “neutral” rating and set a $67.00 price objective on shares of PerkinElmer in a report on Tuesday, September 26th. Evercore ISI began coverage on PerkinElmer in a report on Wednesday, January 3rd. They set an “in-line” rating and a $77.00 price objective on the stock. Finally, ValuEngine downgraded PerkinElmer from a “buy” rating to a “hold” rating in a report on Friday, December 1st. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $72.29.

TRADEMARK VIOLATION NOTICE: “PerkinElmer, Inc. (PKI) to Issue $0.07 Quarterly Dividend” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.watchlistnews.com/perkinelmer-inc-pki-to-issue-0-07-quarterly-dividend/1805594.html.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Dividend History for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.